|1.||Donnelly, Paul S: 2 articles (10/2015 - 08/2010)|
|2.||Ma, Zhong-Ying: 2 articles (02/2014 - 12/2012)|
|3.||Shao, Jia: 2 articles (02/2014 - 12/2012)|
|4.||Xu, Jing-Yuan: 2 articles (02/2014 - 12/2012)|
|5.||Qiao, Xin: 2 articles (02/2014 - 12/2012)|
|6.||Qiang, Zhao-Yan: 2 articles (02/2014 - 12/2012)|
|7.||Lou, Jian-Shi: 2 articles (02/2014 - 12/2012)|
|8.||Ali, Hapipah Mohd: 2 articles (01/2014 - 01/2014)|
|9.||Moghadamtousi, Soheil Zorofchian: 2 articles (01/2014 - 01/2014)|
|10.||Hajrezaie, Maryam: 2 articles (01/2014 - 01/2014)|
12/06/2013 - "In this study, we evaluated the cytotoxic activity of a novel copper(II) complex (LQM402) against cervical cancer cell lines and found that LQM402 exhibited selective cytotoxicity against HeLa and Ca Ski cells. "
12/06/2013 - "Cytotoxic, pro-apoptotic, pro-oxidant, and non-genotoxic activities of a novel copper(II) complex against human cervical cancer."
11/07/2011 - "Synthesis, characterization, plasmid cleavage and cytotoxicity of cancer cells by a copper(II) complex of anthracenyl-terpyridine."
09/01/2010 - "ROS-mediated autophagy was involved in cancer cell death induced by novel copper(II) complex."
09/04/2009 - "The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells."
|3.||Breast Neoplasms (Breast Cancer)
10/01/2015 - "Role of the Copper(II) Complex CupyN5 in Intracellular ROS and Breast Cancer Cell Motility and Invasion."
10/01/2015 - "In vitro antiproliferative and apoptosis-inducing properties of a mononuclear copper(II) complex with dppz ligand, in two genotypically different breast cancer cell lines."
12/01/2012 - "In this study, we investigated the newly synthesized Schiff base copper(II) complex, [Cu(II)(5-Cl-pap)(OAc)(H(2)O)]·2H(2)O (1) (5-Cl-pap=N-2-pyridiylmethylidene-2-hydroxy-5-chloro-phenylamine), inducing growth inhibition and apoptosis in human breast cancer cell line MCF-7 and its potential antitumor mechanism. "
12/01/2012 - "Activities of a novel Schiff base copper(II) complex on growth inhibition and apoptosis induction toward MCF-7 human breast cancer cells via mitochondrial pathway."
10/01/2015 - "In the background that there is concerted effort to discover newer metal-based cancer chemotherapeutic agents that could overcome the limitations in cisplatin and that copper, a biocompatible and redox-active metal, offers potential as alternative to cisplatin, the present study was undertaken to investigate the in vitro anti-proliferative properties of the mononuclear copper(II)complex [Cu(L)(diimine)] + where LH = 2-[(2-dimethylaminoethylimino)methyl]phenol and diimine = dipyrido[3,2-a:2',3'-c]phenazine (dppz) using breast cancer cell lines MCF-7 (ER(+ve) and p53(WT)) and MDA-MB-231(ER(-ve) and p53(mutant)) when cisplatin was used as positive control. "
|4.||Colonic Neoplasms (Colon Cancer)
|5.||Hepatocellular Carcinoma (Hepatoma)
09/01/2012 - "Copper(II) complex (3) possesses the strongest inhibition ratio against human hepatoma cells."
08/15/2012 - "This indicated that the mechanism of action of the novel copper(II) complex was different from that of the parent ligand and suggests that TV117-FM may have a therapeutic role to play in the treatment of hepatocellular carcinoma. "
07/01/1996 - "We report that the incubation of HepG2 cells (a human-derived hepatoma cell line) with the copper(II) complex of 1,10-phenanthroline, CuII(OP)2, results in internucleosomal DNA fragmentation, which is widely recognized as being a hallmark of apoptosis. "
|3.||Schiff Bases (Schiff Base)
|5.||Phenol (Carbolic Acid)
|8.||AMP-Activated Protein Kinases
|9.||Galectin 3 (LGALS3)